Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Literature
1.
Tschoepe D, Menart B, Ferber P et al. (2003) Genetic variation of the platelet surface integrin GPIIb-IIIa (PIA1/PIA2-SNP) shows a high association with Type 2 diabetes mellitus. Diabetologia 46:984–989CrossRefPubMed
2.
Tschoepe D, Menart B, Haastert B, Holle R, Roesen P, Loewel H (2002) The thrombogenic PIA2 allele variant of the platelet fibrinogen receptor GPIIbIIIa is linked with diabetic HbA1c values—results from a representative population sample (the KORA 2000 survey). Diabetologia 45 [Suppl 2]:A408
3.
Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG (2003) Platelet glycoprotein IIb/IIIa PIA2/PIA2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study. J Am Coll Cardiol 42:661–667CrossRefPubMed
Metadata
Title
Author’s Reply
Author
D. Tschoepe
Publication date
01-05-2004
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 5/2004
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-004-1398-3

Other articles of this Issue 5/2004

Diabetologia 5/2004 Go to the issue

Article

Glucagon-like peptide-1 prevents beta cell glucolipotoxicity

Article

Continued increase in the incidence of childhood Type 1 diabetes in a population-based Australian sample (1985–2002)

Review

Control of glycaemia: from molecules to men. Minkowski Lecture 2003

Article

Expression of key genes of fatty acid oxidation, including adiponectin receptors, in skeletal muscle of Type 2 diabetic patients

Article

Oxidative stress induces insulin resistance by activating the nuclear factor-κB pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase

Observation

Unexpected elevation of pentosidine formation in collagen incubated with glucose by low concentrations of the AGE-inhibitor aminoguanidine
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits